Developing a blockchain-based supply chain system for advanced therapies: study protocol

Edward Meinert; Ching Lam; Velthoven M van

doi:10.2196/17005

Developing a blockchain-based supply chain system for advanced therapies: study protocol

Edward Meinert^*, Ching Lam, Velthoven M van

^*Corresponding author for this work

School of Nursing and Midwifery

Research output: Contribution to journal › Article › peer-review

9 Downloads (Pure)

Abstract

Advanced therapies, including cell and gene therapies, have shown therapeutic promise in curing life-threatening diseases such as leukaemia and lymphoma. However, they can be complicated and expensive to deliver due to their sensitivity to environment, troublesome tissue, cell, or genetic material sourcing and complicated regulatory requirements.

Original language	English
Pages (from-to)	0-0
Number of pages	0
Journal	JMIR Research Protocols
Volume	9
Issue number	12
Early online date	14 Dec 2020
DOIs	https://doi.org/10.2196/17005
Publication status	Published - 14 Dec 2020

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.2196/17005

17005-321990-2-RV

Cite this

@article{9c629f0a8c0243a98e4f9d103a812485,

title = "Developing a blockchain-based supply chain system for advanced therapies: study protocol",

abstract = "Advanced therapies, including cell and gene therapies, have shown therapeutic promise in curing life-threatening diseases such as leukaemia and lymphoma. However, they can be complicated and expensive to deliver due to their sensitivity to environment, troublesome tissue, cell, or genetic material sourcing and complicated regulatory requirements.",

author = "Edward Meinert and Ching Lam and van, {Velthoven M}",

year = "2020",

month = dec,

day = "14",

doi = "10.2196/17005",

language = "English",

volume = "9",

pages = "0--0",

journal = "JMIR Research Protocols",

issn = "1929-0748",

publisher = "JMIR Publications Inc.",

number = "12",

}

TY - JOUR

T1 - Developing a blockchain-based supply chain system for advanced therapies: study protocol

AU - Meinert, Edward

AU - Lam, Ching

AU - van, Velthoven M

PY - 2020/12/14

Y1 - 2020/12/14

N2 - Advanced therapies, including cell and gene therapies, have shown therapeutic promise in curing life-threatening diseases such as leukaemia and lymphoma. However, they can be complicated and expensive to deliver due to their sensitivity to environment, troublesome tissue, cell, or genetic material sourcing and complicated regulatory requirements.

AB - Advanced therapies, including cell and gene therapies, have shown therapeutic promise in curing life-threatening diseases such as leukaemia and lymphoma. However, they can be complicated and expensive to deliver due to their sensitivity to environment, troublesome tissue, cell, or genetic material sourcing and complicated regulatory requirements.

UR - https://pearl.plymouth.ac.uk/context/nm-research/article/1273/viewcontent/17005_321990_2_RV.pdf

U2 - 10.2196/17005

DO - 10.2196/17005

M3 - Article

SN - 1929-0748

VL - 9

SP - 0

EP - 0

JO - JMIR Research Protocols

JF - JMIR Research Protocols

IS - 12

ER -

Developing a blockchain-based supply chain system for advanced therapies: study protocol

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this